AIM-HI Accelerator Fund portfolio firm receives Virginia Catalyst funding

ROCKVILLE, MD – A portfolio start-up company of the AIM-HI Accelerator Fund has been awarded $700,000 from Virginia Catalyst to commercialize its lead cancer drug candidate. Richmond-based InterLeukin Combinatorial Therapies (ILCT) is developing unique engineered therapeutic interleukins (a type of protein) which destabilize and can kill cancer cells. The grant was one of six, totaling…

Novela Neurotech showcases smart neural interface at Creative Destruction Lab

TORONTO, ON – Novela Neurotech, a MedTech company developing AI-powered wireless, “smart” neural interface systems, joins Canada’s Creative Destruction Lab to further fine-tune its health technologies to the needs of patients with difficult neurological disorders. “Our core mission is to foster a new era of neurological treatments by focusing on their electrical signaling within the…

Direct-to-consumer fertility tests confuse and mislead consumers, Penn study shows

PHILADELPHIA – Direct-to-consumer hormone-based “fertility testing” for women is viewed by consumers as both an alternative, empowering tool for family planning, and a confusing and misleading one, according to the results of a new study from Penn Medicine. Findings from the small, first-of-its-kind ethnographic study reinforce the need for consumer education around the purpose and…

5 Types of Divorced Men

Everyone survives divorce in different ways. This article will tell you how men cope with worrying. Below we will talk about five types of divorced men. Hachiko He still has not let go his ex-wife. Spoiler: he won’t let her go – he will suffer and experience drama for a long time. There will always…

Plan Your Play, Play Your Plan

Good morning. Straight talk, no malarkey: I don’t like New Year’s Eve. I grew up in New York City and work in Times Square, and my view of the holiday has always been informed by the crowds here and the fences that contain them, the way they wait and wait. Wake up, sheeple! It’s cold…